Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Warner Bros
WBD
|
+$130M |
| 2 |
Tesla
TSLA
|
+$76.4M |
| 3 |
Roblox
RBLX
|
+$50.1M |
| 4 |
VICI Properties
VICI
|
+$43.2M |
| 5 |
Danaher
DHR
|
+$41.2M |
Top Sells
| 1 |
AT&T
T
|
+$209M |
| 2 |
CERN
Cerner Corp
CERN
|
+$119M |
| 3 |
Baidu
BIDU
|
+$91.9M |
| 4 |
Canadian National Railway
CNI
|
+$53.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$37.5M |
Sector Composition
| 1 | Technology | 26.45% |
| 2 | Healthcare | 15.87% |
| 3 | Consumer Discretionary | 11.68% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Myers Industries
MYE
$587M
| $1.66M | ﹤0.01% |
72,900
| – | – |
|
2052
Enact Holdings
ACT
$5.74B
| $1.65M | ﹤0.01% |
+76,700
| New | +$1.65M |
|
2053
Bally's
BALY
$487M
| $1.65M | ﹤0.01% |
83,225
+6,100
| +8% | +$121K |
|
|
UHT
2054
Universal Health Realty Income Trust
UHT
$575M
| $1.64M | ﹤0.01% |
30,900
-1,700
| -5% | -$90.4K |
|
|
MCHB
2055
Mechanics Bancorp Class A Common Stock
MCHB
$3.03B
| $1.64M | ﹤0.01% |
47,400
-1,000
| -2% | -$34.7K |
|
2056
Crinetics Pharmaceuticals
CRNX
$3.2B
| $1.64M | ﹤0.01% |
88,000
+9,300
| +12% | +$173K |
|
|
NGD
2057
New Gold Inc
NGD
$5.16B
| $1.64M | ﹤0.01% |
1,539,162
| – | – |
|
2058
Planet Labs
PL
$3.01B
| $1.64M | ﹤0.01% |
+377,700
| New | +$1.64M |
|
|
KDNY
2059
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.64M | ﹤0.01% |
+93,500
| New | +$1.64M |
|
2060
Camtek
CAMT
$3.98B
| $1.63M | ﹤0.01% |
67,767
| – | – |
|
|
ROCC
2061
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.63M | ﹤0.01% |
+49,700
| New | +$1.63M |
|
2062
Genesco
GCO
$358M
| $1.63M | ﹤0.01% |
32,700
-1,300
| -4% | -$64.9K |
|
2063
New Oriental
EDU
$8.79B
| $1.63M | ﹤0.01% |
80,023
-345,531
| -81% | -$7.03M |
|
2064
Catalyst Pharmaceutical
CPRX
$2.44B
| $1.62M | ﹤0.01% |
231,700
| – | – |
|
2065
Clover Health Investments
CLOV
$1.57B
| $1.62M | ﹤0.01% |
757,800
+54,500
| +8% | +$117K |
|
2066
Hawkins
HWKN
$3.62B
| $1.62M | ﹤0.01% |
44,988
| – | – |
|
|
GMRE
2067
Global Medical REIT
GMRE
$512M
| $1.62M | ﹤0.01% |
144,200
| – | – |
|
|
EQRX
2068
DELISTED
EQRx, Inc. Common Stock
EQRX
| $1.62M | ﹤0.01% |
+344,500
| New | +$1.62M |
|
2069
Horizon Bancorp
HBNC
$833M
| $1.61M | ﹤0.01% |
92,550
| – | – |
|
2070
Hanmi Financial
HAFC
$748M
| $1.61M | ﹤0.01% |
+71,800
| New | +$1.61M |
|
2071
Kelly Services Class A
KELYA
$481M
| $1.61M | ﹤0.01% |
81,000
| – | – |
|
2072
First Advantage
FA
$2.75B
| $1.6M | ﹤0.01% |
126,500
| – | – |
|
2073
Health Catalyst
HCAT
$220M
| $1.6M | ﹤0.01% |
110,400
+5,800
| +6% | +$84.1K |
|
2074
Perion Network
PERI
$418M
| $1.6M | ﹤0.01% |
88,586
-5,084
| -5% | -$91.7K |
|
|
ARR
2075
Armour Residential REIT
ARR
$1.72B
| $1.59M | ﹤0.01% |
45,242
+2,820
| +7% | +$99.3K |
|